Estrogen-Induced μ-Opioid Receptor Internalization in the Medial Preoptic Nucleus Is Mediated via Neuropeptide Y-Y1 Receptor Activation in the Arcuate Nucleus of Female Rats

Journal of Neuroscience

Volumn 24, Issue 4, 2004, Pages 947-955

  Mills, Richard H ^a,b   Sohn, Richard K ^a   Micevych, Paul E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Estrogen; Hypothalamus; Internalization; Lordosis; Progesterone; Receptors; Reproduction

Indexed keywords

BETA ENDORPHIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSINE DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE; ESTRADIOL; ESTROGEN; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NEUROPEPTIDE Y [31 CYSTEINE 34 NORVALINE]; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; PEPTIDE DERIVATIVE; SEX HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; ESTROGEN ACTIVITY; FEMALE; HORMONE ACTION; HYPOTHALAMUS; INTERNALIZATION; LORDOSIS; MEDIAL PREOPTIC AREA; NERVE CELL; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REPRODUCTION; SEXUAL BEHAVIOR;

ANIMALS; ARCUATE NUCLEUS; ESTRADIOL; ESTROGENS; FEMALE; NEURONS; NEUROPEPTIDE Y; OVARIECTOMY; POSTURE; PREOPTIC AREA; PROGESTERONE; RATS; RATS, LONG-EVANS; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, OPIOID, MU; SEXUAL BEHAVIOR, ANIMAL; SOMATOSTATIN;

EID: 0742270489     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1366-03.2004     Document Type: Article

References (64)

1. Abercrombie M (1946) Estimation of nuclear population from microtome sections. Anat Rec 94:239-247.
2. Barden N, Merand Y, Rouleau D, Garon M, Dupont A (1981) Changes in the beta-endorphin content of discrete hypothalamic nuclei during the estrous cycle of the rat. Brain Res 204:441-445.
3. Baskin DG, Norwood BJ, Schwartz MW, Koerker DJ (1995) Estradiol inhibits the increase of hypothalamic neuropeptide Y messenger ribonucleic acid expression induced by weight loss in ovariectomized rats. Endocrinology 136:5547-5554.
4. Belcheva MM, Coscia CJ (2002) Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11:34-44.
5. Besecke LM, Wolfe AM, Pierce ME, Takahashi JS, Levine JE (1994) Neuropeptide Y stimulates luteinizing hormone-releasing hormone release from superfused hypothalamic GT1-7 cells. Endocrinology 135:1621-1627.
6. Borsodi A, Toth G (1995) Characterization of opioid receptor types and subtypes with new ligands. Ann NY Acad Sci 757:339-352.
7. Broberger C, Landry M, Wong H, Walsh JN, Hokfelt T (1997) Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in proopiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66:393-408.
8. Cator AD, DeJoseph MR, Urban JH (2002) Distribution of NPY receptors and estrogen receptors in rat hypothalamus. Soc Neurosci Abstr 73.4.
9. Cheung S, Hammer Jr RP (1995) Gonadal steroid hormone regulation of proopiomelanocortin gene expression in arcuate neurons that innervate the medial preoptic area of the rat. Neuroendocrinology 62:283-292.
10. Cheung S, Salinas J, Hammer Jr RP (1995) Gonadal steroid hormone-dependence of beta-endorphin-like immunoreactivity in the medial preoptic area of the rat. Brain Res 675:83-88.
11. Clark JT, Kalra PS, Kalra SP (1985) Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117:2435-2442.
12. Corp ES, Greco B, Powers JB, Bivens CL, Wade GN (2001) Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters. Am J Physiol Regul Integr Comp Physiol 280:R1061-R1068.
13. Crowley WR, Tessel RE, O'Donohue TL, Adler BA, Kalra SP (1985) Effects of ovarian hormones on the concentrations of immunoreactive neuropeptide Y in discrete brain regions of the female rat: correlation with serum luteinizing hormone (LH) and median eminence LH-releasing hormone. Endocrinology 117:1151-1155.
14. Daaka Y, Luttrell LM, Ahn S, Della Rocca GJ, Ferguson SS, Caron MG, Lefkowitz RJ (1998) Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem 273:685-688.
15. Dournaud P, Boudin H, Schonbrunn A, Tannenbaum GS, Beaudet A (1998) Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin. J Neurosci 18:1056-1071.
16. Eckersell CB, Popper P, Micevych PE (1998) Estrogen-induced alteration of μ-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala. J Neurosci 18:3967-3976.
17. Finley JC, Lindstrom P, Petrusz P (1981) Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33:28-42.
18. Fuxe K, Tinner B, Caberlotto L, Bunnemann B, Agnati LF (1997) NPY Y1 receptor like immunoreactivity exists in a subpopulation of beta-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat. Neurosci Lett 225:49-52.
19. Fuxe R, Agnati L, Zoli M, Cintra A, Härfstrand A, von Euler G, Grimaldi R, Kalia M, Eneroth P (1998) The opioid peptide systems: their organization and role in volume transmission and neuroendocrine regulation. In: Regulatory roles of opioid peptides (Illes P, Farsang C, eds), pp 33-68. New York: Weinheim.
20. Gorzalka BB, Heddema GM, Lester GL, Hanson LA (1997) Beta-endorphin inhibits and facilitates lordosis behaviour in rats depending on ventricular site of administration. Neuropeptides 31:517-521.
21. Holland KL, Norby LA, Micevych PE (1998) Peripubertal ontogeny and estrogen stimulation of cholecystokinin and preproenkephalin mRNA in the rat hypothalamus and limbic system. J Comp Neurol 392:48-57.
22. Ignatova EG, Belcheva MM, Bohn LM, Neuman MC, Coscia CJ, (1999) Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence. J Neurosci 19:56-63.
23. Jain MR, Pu S, Kalra PS, Kalra SP (1999) Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors. Endocrinology 140:5171-5177.
24. Jirikowski GF, Merchenthaler I, Rieger GE, Stumpf WE (1986) Estradiol target sites immunoreactive for beta-endorphin in the arcuate nucleus of rat and mouse hypothalamus. Neurosci Lett 65:121-126.
25. Kalra SP, Fuentes M, Fournier A, Parker SL, Crowley WR (1992) Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats. Endocrinology 130:3323-3330.
26. Khachaturian H, Alessi NE, Munfakh N, Watson SJ (1983) Ontogeny of opioid and related peptides in the rat cns and pituitary: an immunocytochemical study. Life Sci 33 [Suppl 1]:61-64.
27. Leupen SM, Besecke LM, Levine JE (1997) Neuropeptide Y Y1-receptor stimulation is required for physiological amplification of preovulatory luteinizing hormone surges. Endocrinology 138:2735-2739.
28. Li C, Chen P, Smith MS (1999) Morphological evidence for direct interaction between arcuate nucleus neuropeptide Y (NPY) neurons and gonadotropin-releasing hormone neurons and the possible involvement of NPY Y1 receptors. Endocrinology 140:5382-5390.
29. Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ (1997) G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem 272:31648-31656.
30. Mani S (2001) Ligand-independent activation of progestin receptors in sexual receptivity. Horm Behav 40:183-190.
31. Mantyh PW, Allen CJ, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE (1995) Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci USA 92:2622-2626.
32. Micevych PE, Elde RP (1982) Neurons containing alpha-melanocyte stimulating hormone and beta-endorphin immunoreactivity in the cat hypothalamus. Peptides 3:655-662.
33. Micevych PE, Eckersell CB, Brecha N, Holland KL (1997) Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit. Brain Res Bull 44:335-343.
34. Migita K, Loewy AD, Ramabhadran TV, Krause JE, Waters SM (2001) Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res 889:23-37.
35. Mikkelsen JD, Larsen PJ (1992) A high concentration of NPY (Y1)-receptor mRNA-expressing cells in the rat arcuate nucleus. Neurosci Lett 148:195-198.
36. Mills RH, Sohn RK, Micevych PE (2001) Neuropeptide Y facilitates mu-opioid receptor activation in the medial preoptic nucleus in female rats. Horm Behav 39:339.
37. Morrell JI, McGinty JF, Pfaff DW (1985) A subset of beta-endorphin- or dynorphin-containing neurons in the medial basal hypothalamus accumulates estradiol. Neuroendocrinology 41:417-426.
38. Mundell SJ, Matharu AL, Pula G, Roberts PJ, Kelly E (2001) Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin- and dynamin-dependent. J Neurochem 78:546-551.
39. Osterlund M, Kuiper GG, Gustafsson JA, Hurd YL (1998) Differential distribution and regulation of estrogen receptor-alpha and -beta mRNA within the female rat brain. Brain Res Mol Brain Res 54:175-180.
40. Parker SL, Carroll BL, Kalra SP, St. Pierre S, Fournier A, Crowley WR (1996) Neuropeptide Y Y2 receptors in hypothalamic neuroendocrine areas are up-regulated by estradiol and decreased by progesterone cotreatment in the ovariectomized rat. Endocrinology 137:2896-2900.
41. Petraglia F, Penalva A, Locatelli V, Cocchi D, Panerai AE, Genazzani AR, Muller EE (1982) Effect of gonadectomy and gonadal steroid replacement on pituitary and plasma beta-endorphin levels in the rat. Endocrinology 111:1224-1229.
42. Pickel VM, Beck-Sickinger AG, Chan J, Weiland HA (1998) Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res 52:54-68.
43. Priest CA, Roberts JL (2000) Estrogen and tamoxifen differentially regulate beta-endorphin and cFos expression and neuronal colocalization in the arcuate nucleus of the rat. Neuroendocrinology 72:293-305.
44. Priest CA, Eckersell CB, Micevych PE (1995) Estrogen regulates preproenkephalin-A mRNA levels in the rat ventromedial nucleus: temporal and cellular aspects. Brain Res Mol Brain Res 28:251-262.
45. Sahu A, Phelps CP, White JD, Crowley WR, Kalra SP, Kalra PS (1992) Steroidal regulation of hypothalamic neuropeptide Y release and gene expression. Endocrinology 130:3331-3336.
46. Sar M, Sahu A, Crowley WR, Kalra SP (1990) Localization of neuropeptide-Y immunoreactivity in estradiol-concentrating cells in the hypothalamus. Endocrinology 127:2752-2756.
47. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388:507-525.
48. Sinchak K, Micevych P (2003) Visualizing activation of opioid circuits by internalization of G protein-coupled receptors. Mol Neurobiol 27:197-222.
49. Sinchak K, Micevych PE (2001) Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior. J Neurosci 21:5723-5729.
50. Sirinathsinghji DJ (1984) Modulation of lordosis behavior of female rats by naloxone, beta-endorphin and its antiserum in the mesencephalic central gray: possible mediation via GnRH. Neuroendocrinology 39:222-230.
51. Sirinathsinghji DJ (1986) Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area. Brain Res 375:49-56.
52. Sirinathsinghji DJ, Whittington PE, Audsley A, Fraser HM (1983) beta-Endorphin regulates lordosis in female rats by modulating LH-RH release. Nature 301:62-64.
53. Swanson LW (1998) Brain maps: structure of the rat brain. Amsterdam: Elsevier.
54. Torii M, Kubo K (1994) The effects of intraventricular injection of beta-endorphin on initial estrogen action to induce lordosis behavior. Physiol Behav 55:157-162.
55. Torii M, Kubo K, Sasaki T (1999) Facilitatory and inhibitory effects of beta-endorphin on lordosis in female rats: relation to time of administration. Horm Behav 35:271-278.
56. Vieira AV, Lamaze C, Schmid SL (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274:2086-2089.
57. von Zastrow M, Link R, Daunt D, Barsh G, Kobilka B (1993) Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem 268:763-766.
58. Wardlaw SL, Thoron L, Frantz AG (1982) Effects of sex steroids on brain beta-endorphin. Brain Res 245:327-331.
59. Wiesner JB, Moss RL (1984) Beta-endorphin suppression of lordosis behavior in female rats; lack of effect of peripherally-administered naloxone. Life Sci 34:1455-1462.
60. Wilcox JN, Roberts JL (1985) Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels. Endocrinology 117:2392-2396.
61. Wilcox JN, Roberts JL, Chronwall BM, Bishop JF, O'Donohue T (1986) Localization of proopiomelanocortin mRNA in functional subsets of neurons defined by their axonal projections. J Neurosci Res 16:89-96.
62. Xu M, Urban JH, Hill JW, Levine JE (2000) Regulation of hypothalamic neuropeptide Y Y1 receptor gene expression during the estrous cycle: role of progesterone receptors. Endocrinology 141:3319-3327.
63. Zadina JE, Martin-Schild S, Gerall AA, Kastin AJ, Hackler L, Ge LJ, Zhang X (1999) Endomorphins: novel endogenous mu-opiate receptor agonists in regions of high mu-opiate receptor density. Ann NY Acad Sci 897:136-144.
64. Zaki PA, Keith Jr DE, Brine GA, Carroll FI, Evans CJ (2000) Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? J Pharmacol Exp Ther 292:1127-1134.